Hearts of Athletes
The Hearts of Athletes study is being conducted to determine the heart involvement with COVID-19 in athletes. This study aims to enroll any Adult (18 years of age or greater) • Athlete is defined as NCAA Collegiate Athlete, Professional Athlete, Military, or Olympic Athlete will be eligible for the study. With COVID-19 • COVID-19 diagnosed via an RT-PCR (nasal or throat swab test) prior to enrollment Or without COVID-19 • Identified as a local Control participant (similar sport) to a participant with COVID-19, who is willing to undergo a standard cardiovascular evaluation Participants with and without COVID-19 will use their mobile devices to provide health information, like symptoms, by answering survey questions daily for 30 days. Also, participants will allow their de-identified cardiac images to be sent to the Duke Heart Center for blinded analysis. No physical risks are associated with this study. One possible risk, although minimal, is loss of confidentiality.
Conditions:
🦠 Cardiac Involvement With COVID-19
🗓️ Study Start (Actual) 3 November 2022
🗓️ Primary Completion (Estimated) 31 July 2024
✅ Study Completion (Estimated) 31 July 2024
👥 Enrollment (Estimated) 500
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Durham, North Carolina, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * Any adult athlete (defined as NCAA Collegiate Athlete, Professional Athlete, or Olympic Athlete) will be eligible for the study.
    • * COVID-19 diagnosed via an RT-PCR, or history of COVID-19 antibodies at least 10 days and less than 6 months prior to consent
    • * No longer requiring quarantine per local health recommendations, prior to cardiovascular evaluation.
    • * Identification as a Control participant (similar sport) to a participant without COVID-19 willing to undergo cardiovascular evaluation

    Exclusion Criteria:

    • * Anyone with known cardiovascular disease - defined as known myocardial disease, valvular heart disease, or known coronary heart disease
    • * Anyone without the ability to provide informed consent
    • * Anyone with a known contraindication to cardiac magnetic resonance (metallic implant)
Ages Eligible for Study: 18 Years to 30 Years (ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 29 January 2021
  • First Submitted that Met QC Criteria 29 January 2021
  • First Posted 3 February 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 26 October 2023
  • Last Update Posted 27 October 2023
  • Last Verified October 2023